Series A Round
€5M target
Investors
Coimbra Genomics develops genome-based clinical decision support systems. Our first-in-class software platform – called ELSIE® – allows any physician, anywhere, to consult their patients’ genome through standardized queries, during a regular medical appointment. We've created the first simple, scalable and secure way to perform truly personalized medicine....
Coimbra Genomics develops genome-based clinical decision support systems. Our first-in-class software platform – called ELSIE® – allows any physician, anywhere, to consult their patients’ genome through standardized queries, during a regular medical appointment. We've created the first simple, scalable and secure way to perform truly personalized medicine.
More information

Investors